Alternatives in Cancer Therapy

Transforming Growth Factor-Beta in Cancer Therapy, Volume II: Cancer Treatment and Therapy

Transforming Growth Factor-Beta in Cancer Therapy, Volume II: Cancer Treatment and Therapy by Sonia B. Jakowlew and C.-H. Heldin
English | ISBN: 1588297152 | 2008 | PDF | 743 pages | 61,6 mb

Proteasome Inhibitors in Cancer Therapy  eBooks & eLearning

Posted by MoneyRich at Nov. 17, 2016
Proteasome Inhibitors in Cancer Therapy

Proteasome Inhibitors in Cancer Therapy by Julian Adams
English | 25 May 2004 | ISBN: 1588292509 | 340 Pages | PDF | 7 MB

A panel of leading academic and pharmaceutical investigators takes stock of the remarkable work that has been accomplished to date with proteasome inhibitors in cancer, and examines emerging therapeutic possibilities. The topics range from a discussion of the chemistry and cell biology of the proteasome and the rationale for proteasome inhibitors in cancer to a review of current clinical trials underway.

Transforming Growth Factor-Beta in Cancer Therapy, Volume II (repost)  eBooks & eLearning

Posted by MoneyRich at Oct. 13, 2016
Transforming Growth Factor-Beta in Cancer Therapy, Volume II (repost)

Transforming Growth Factor-Beta in Cancer Therapy, Volume II: Cancer Treatment and Therapy: v. 2 by Sonia B. Jakowlew
English | 25 Mar. 2008 | ISBN: 1588297152 | 786 Pages | PDF | 62 MB

Transforming Growth Factor- ß in Cancer Therapy, Vols. 1 and 2, provides a compendium of findings about the role of transforming growth factor- ß (TGF- ß) in cancer treatment and therapy. The second volume, Cancer Treatment in Therapy, is divided into three parts.

Tumor Targeting in Cancer Therapy  eBooks & eLearning

Posted by MoneyRich at Oct. 13, 2016
Tumor Targeting in Cancer Therapy

Tumor Targeting in Cancer Therapy by Michel Pagé
English | 19 May 2010 | ISBN: 161737251X | 476 Pages | PDF | 11 MB

In Tumor Targeting in Cancer Therapy, Dr. Michel Pagé and a panel of authoritative experts from the drug industry, clinics, and academia introduce the principles and techniques of tumor targeting and critically survey their applications from laboratory to bedside.

Matrix Metalloproteinase Inhibitors in Cancer Therapy  eBooks & eLearning

Posted by tanas.olesya at July 15, 2016
Matrix Metalloproteinase Inhibitors in Cancer Therapy

Matrix Metalloproteinase Inhibitors in Cancer Therapy by Neil J. Clendeninn
English | 17 Sept. 2000 | ISBN: 0896036685 | 280 Pages | PDF | 2 MB

Cutting-edge investigators review the current status of the entire field, from the biology of MMPs through the current clinical studies.

Antifolate Drugs in Cancer Therapy  eBooks & eLearning

Posted by MoneyRich at Dec. 11, 2015
Antifolate Drugs in Cancer Therapy

Antifolate Drugs in Cancer Therapy by Ann Jackman
English | 24 Mar. 2013 | ISBN: 1475745214 | 472 Pages | PDF | 13 MB

Antifolates are an important class of anticancer drugs originally developed as anti leu­ kemic agents, but now used, usually in combination with other drugs, for the treatment of a wide range of tumors, notably carcinomas of the head and neck, breast, germ cell tumors, non-Hodgkin's lymphoma, acute lymphoblastic leukemia, and osteogenic sar­ comas. 5-Fluorouracil and its prodrugs also target, in part, the folate-dependent enzyme, thymidylate synthase.

Lipid A in Cancer Therapy (Advances in Experimental Medicine and Biology)  eBooks & eLearning

Posted by alt_f4 at Sept. 9, 2015
Lipid A in Cancer Therapy (Advances in Experimental Medicine and Biology)

Lipid A in Cancer Therapy (Advances in Experimental Medicine and Biology) by Jean-Francois Jeannin
English | Nov. 18, 2009 | ISBN: 1441916024 | 145 Pages | PDF | 17 MB

Cancer remains a major challenge for modern society. Not only does cancer rank among the first three causes of mortality in most population groups but also the therapeutic options available for most tumor types are limited.

Fluoropyrimidines in Cancer Therapy (Cancer Drug Discovery and Development)  eBooks & eLearning

Posted by alt_f4 at Sept. 9, 2015
Fluoropyrimidines in Cancer Therapy (Cancer Drug Discovery and Development)

Fluoropyrimidines in Cancer Therapy (Cancer Drug Discovery and Development) by Youcef M. Rustum
English | Dec. 2, 2002 | ISBN: 0896039560 | 340 Pages | PDF | 5 MB

Leading cancer researchers update and review the mechanisms of action and the therapeutic selectivity and efficacy of 5-FU with and without leucovorin and its prodrugs in the treatment of colorectal cancer. Among the combination agents considered are UFT/LV, 5-FU/EU, capecitabine (Xeloda), S-1, and a variety of thymidylate synthase inhibitors.

Checkpoint Responses in Cancer Therapy  eBooks & eLearning

Posted by alt_f4 at Sept. 8, 2015
Checkpoint Responses in Cancer Therapy

Checkpoint Responses in Cancer Therapy (Cancer Drug Discovery and Development) by Wei Dai
English | June 6, 2008 | ISBN: 1588299309 | 320 Pages | PDF | 6.5 MB

Extensive research has uncovered a set of molecular surveillance mechanisms – commonly called “checkpoints” – which tightly monitor cell-cycle processes. Today’s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets.

Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development)  eBooks & eLearning

Posted by alt_f4 at Sept. 8, 2015
Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development)

Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development) by Wafik S. El-Deiry
English | Dec. 3, 2004 | ISBN: 1588291723 | 387 Pages | PDF | 7 MB

An in depth review of our latest understanding of the molecular events that regulate cell death and those molecules that provide targets for developing agonists or antagonists to modulate death signaling for therapeutic purposes.